Masimo (MASI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
A merger agreement was entered into for Masimo to be acquired by Danaher, with Masimo becoming a wholly owned subsidiary of Danaher following the merger, pending shareholder approval at a special meeting scheduled for May 1, 2026.
The board recommends voting in favor of the merger and related proposals, and supplemental disclosures have been provided to address shareholder litigation and demands for additional information.
The merger process included outreach to multiple potential acquirors, with Danaher ultimately offering $180 per share in cash as its best and final offer.
Forward-looking statements highlight risks related to the merger's completion, regulatory approvals, potential competing offers, and the impact on business operations.
Voting matters and shareholder proposals
Shareholders are asked to vote on the adoption of the merger agreement and related proposals at a special meeting.
The board continues to recommend a "FOR" vote on all proposals, including the merger.
Board of directors and corporate governance
The board formed a working group, including the chair and vice chair, to coordinate the sale process and provide updates, with all material decisions reserved for the full board.
No additional compensation was provided to working group members for their roles.
Latest events from Masimo
- Revenue up 8.5% to $403.6M; merger with Danaher approved; net income $57.1M.MASI
Q1 20266 May 2026 - Merger with Danaher and executive compensation proposals both approved by shareholders.MASI
EGM 20264 May 2026 - Shareholders to vote on $180/share all-cash merger with Danaher and related executive compensation.MASI
Proxy filing1 Apr 2026 - Stockholders to vote on $180/share Danaher acquisition, with board unanimous support and premium offered.MASI
Proxy Filing18 Mar 2026 - $1B credit facility signed in Dec 2025 with leverage and coverage covenants, maturing 2030.MASI
Q4 202527 Feb 2026 - Masimo to be acquired by Danaher for $180 per share, pending shareholder approval.MASI
Proxy Filing17 Feb 2026 - Board approves $180/share Danaher acquisition; shareholder vote and regulatory review pending.MASI
Proxy Filing17 Feb 2026 - Shareholders will vote on a $180/share all-cash merger, with closing expected in late 2026.MASI
Proxy Filing17 Feb 2026 - Q2 revenue up 9% to $496.3M, driven by healthcare growth; non-GAAP EPS $0.86, guidance raised.MASI
Q2 20242 Feb 2026